-
公开(公告)号：US20240285608A1
公开(公告)日：2024-08-29
申请号：US18627244
申请日：2024-04-04
发明人： Paul Edward STAMETS
IPC分类号： A61K31/455 , A61K31/4045 , A61K31/675 , A61K36/07
CPC分类号： A61K31/455 , A61K31/4045 , A61K31/675 , A61K36/07
摘要： Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
-
公开(公告)号：US20240285607A1
公开(公告)日：2024-08-29
申请号：US18627162
申请日：2024-04-04
发明人： Paul Edward STAMETS
IPC分类号： A61K31/455 , A61K31/4045 , A61K31/675 , A61K36/07
CPC分类号： A61K31/455 , A61K31/4045 , A61K31/675 , A61K36/07
摘要： Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients. In another aspect, tryptamine compositions described herein enhance neuroplasticity by promoting neuronal branching through the formation of neurites (i.e., neurite outgrowth) and neurite elongation (i.e., increasing neurite length).
-
公开(公告)号：US20240122914A1
公开(公告)日：2024-04-18
申请号：US18531407
申请日：2023-12-06
发明人： Paul Edward STAMETS
IPC分类号： A61K31/455 , A61K31/4045 , A61K31/675 , A61K36/07
CPC分类号： A61K31/455 , A61K31/4045 , A61K31/675 , A61K36/07
摘要： Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
-
公开(公告)号：US11850254B2
公开(公告)日：2023-12-26
申请号：US17669919
申请日：2022-02-11
发明人： Paul Edward Stamets
IPC分类号： A61K31/661 , A61K36/07 , A61K36/73 , A61P25/24 , A61K31/352 , A61K31/455 , A61K36/066 , A61K31/05 , A61K9/08 , A61K31/4045 , A61K36/06 , A61K36/185
CPC分类号： A61K31/661 , A61K9/08 , A61K31/05 , A61K31/352 , A61K31/4045 , A61K31/455 , A61K36/06 , A61K36/066 , A61K36/07 , A61K36/185 , A61K36/73 , A61P25/24
摘要： Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
-
公开(公告)号：US20220370483A1
公开(公告)日：2022-11-24
申请号：US17738925
申请日：2022-05-06
发明人： Paul E. STAMETS
IPC分类号： A61K31/675 , A61K36/06 , A61K45/06 , A61P25/28
摘要： Described herein are fungal compound compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect, the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof, optionally combined with one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum), or combinations thereof, optionally one or more adversive compounds, optionally one or more monoamine oxidase inhibitor (MAOI) compounds, and optionally one or more pharmaceutically acceptable excipients.
-
公开(公告)号：US20210308201A1
公开(公告)日：2021-10-07
申请号：US17221411
申请日：2021-04-02
发明人： Paul E. STAMETS
IPC分类号： A61K36/074 , A61K36/07 , A61K47/10 , A61K47/02 , A61K45/06 , A61K31/716 , A61P37/06 , A61P31/12
摘要： Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mushroom mycelium and/or fruit body mixture, optionally combined with one or more buffering agents, ethanol, and water.
-
公开(公告)号：US20240108640A1
公开(公告)日：2024-04-04
申请号：US18475724
申请日：2023-09-27
发明人： Paul Edward STAMETS
IPC分类号： A61K31/661 , A61K9/08 , A61K31/05 , A61K31/352 , A61K31/4045 , A61K31/455 , A61K36/06 , A61K36/066 , A61K36/07 , A61K36/185 , A61K36/73 , A61P25/24
CPC分类号： A61K31/661 , A61K9/08 , A61K31/05 , A61K31/352 , A61K31/4045 , A61K31/455 , A61K36/06 , A61K36/066 , A61K36/07 , A61K36/185 , A61K36/73 , A61P25/24
摘要： Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
-
公开(公告)号：US20230414687A1
公开(公告)日：2023-12-28
申请号：US18446315
申请日：2023-08-08
发明人： Paul E. STAMETS
IPC分类号： A61K36/074 , A61K36/07 , A61K47/10 , A61P31/12 , A61K45/06 , A61K31/716 , A61P37/06 , A61K47/02
CPC分类号： A61K36/074 , A61K36/07 , A61K47/10 , A61K47/02 , A61K45/06 , A61K31/716 , A61P37/06 , A61P31/12
摘要： Described herein are combined fungal compositions for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that causes an inflammatory response. In one aspect the composition comprises an aqueous or solid fraction of Trametes versicolor and Fomitopsis officinalis mycelium, fermented substrates thereof, or combinations thereof.
-
公开(公告)号：US20230380387A1
公开(公告)日：2023-11-30
申请号：US18447127
申请日：2023-08-09
发明人： Paul Edward STAMETS
IPC分类号： A01K53/00
CPC分类号： A01K53/00
摘要： A bee feeding apparatus having labyrinthine passages. The apparatus is useful for dispensing water, bee feeding supplements, or treatments to wild or domesticated bees. The circuitous entryway hinders or inhibits other insects such as wasps, hornets, or yellow jackets from entering the innermost regions of the feeder and accessing the bee feeding supplements.
-
公开(公告)号：US20230210872A1
公开(公告)日：2023-07-06
申请号：US18115966
申请日：2023-03-01
发明人： Paul Edward STAMETS
IPC分类号： A61K31/4045 , A61K31/455 , A61K36/06 , A61K36/185 , A61P25/24 , A61K9/08
CPC分类号： A61K31/4045 , A61K31/455 , A61K36/06 , A61K36/185 , A61P25/24 , A61K9/08
摘要： Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica, or Cannabis ruderalis, optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.
-
-
-
-
-
-
-
-
-
搜索结果
30 条记录 (耗时 0.019 秒)
